|
|
|
|
|
R
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
£
|
TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
20-3179218
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1040 Avenue of the Americas, 16
th
Floor
|
|
|
New York, New York
|
|
10018
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
|
|
|
|
Page
|
PART I.
|
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
|
|
||
|
|
Condensed Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011
|
|
|
|
|
Condensed Consolidated Statements of Operations for the three months ended March 31, 2012 and 2011
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2012 and 2011
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and 2011
|
|
|
|
|
Notes to the Condensed Consolidated Financial Statements
|
|
|
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
PART II.
|
|
OTHER INFORMATION
|
|
|
Item 1.
|
|
|
||
|
|
|
|
|
Item 1A.
|
|
|
||
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
Item 5.
|
|
|
||
|
|
|
|
|
Item 6.
|
|
|
||
|
|
|
|
|
SIGNATURES
|
|
|||
|
|
|
|
|
Certification of CEO Pursuant to Section 302
|
|
|
||
Certification of CFO Pursuant to Section 302
|
|
|
||
Certification of CEO Pursuant to Section 906
|
|
|
||
Certification of CFO Pursuant to Section 906
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
March 31,
2012 |
|
December 31, 2011
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
62,766
|
|
|
$
|
55,237
|
|
Investments
|
5,966
|
|
|
4,983
|
|
||
Accounts receivable, net of allowance for doubtful accounts of $1,515 and $1,515
|
18,780
|
|
|
20,684
|
|
||
Deferred income taxes—current
|
641
|
|
|
509
|
|
||
Prepaid and other current assets
|
2,810
|
|
|
2,190
|
|
||
Total current assets
|
90,963
|
|
|
83,603
|
|
||
Fixed assets, net
|
8,850
|
|
|
8,726
|
|
||
Acquired intangible assets, net
|
54,631
|
|
|
56,471
|
|
||
Goodwill
|
177,916
|
|
|
176,365
|
|
||
Deferred financing costs, net of accumulated amortization of $765 and $650
|
842
|
|
|
957
|
|
||
Other assets
|
306
|
|
|
256
|
|
||
Total assets
|
$
|
333,508
|
|
|
$
|
326,378
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable and accrued expenses
|
$
|
14,723
|
|
|
$
|
14,599
|
|
Deferred revenue
|
69,698
|
|
|
60,887
|
|
||
Current portion of acquisition related contingencies
|
—
|
|
|
1,557
|
|
||
Current portion of long-term debt
|
4,000
|
|
|
4,000
|
|
||
Income taxes payable
|
3,592
|
|
|
2,929
|
|
||
Total current liabilities
|
92,013
|
|
|
83,972
|
|
||
Long-term debt
|
10,000
|
|
|
11,000
|
|
||
Deferred income taxes—non-current
|
16,586
|
|
|
17,167
|
|
||
Accrual for unrecognized tax benefits
|
4,078
|
|
|
3,869
|
|
||
Other long-term liabilities
|
1,153
|
|
|
1,154
|
|
||
Total liabilities
|
123,830
|
|
|
117,162
|
|
||
Commitments and contingencies (Note 7)
|
|
|
|
||||
Stockholders’ equity
|
|
|
|
||||
Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding
|
—
|
|
|
—
|
|
||
Common stock, $.01 par value, authorized 240,000; issued 70,366 and 69,364 shares, respectively; outstanding: 64,674 and 65,070 shares, respectively
|
704
|
|
|
694
|
|
||
Additional paid-in capital
|
287,563
|
|
|
285,153
|
|
||
Accumulated other comprehensive loss
|
(9,968
|
)
|
|
(12,052
|
)
|
||
Accumulated deficit
|
(12,882
|
)
|
|
(21,501
|
)
|
||
Treasury stock, 5,692 and 4,294 shares, respectively
|
(55,739
|
)
|
|
(43,078
|
)
|
||
Total stockholders’ equity
|
209,678
|
|
|
209,216
|
|
||
Total liabilities and stockholders’ equity
|
$
|
333,508
|
|
|
$
|
326,378
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
|
|
2012
|
|
2011
|
||||
Revenues
|
|
|
|
|
$
|
46,132
|
|
|
$
|
40,089
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||
Cost of revenues
|
|
|
|
|
3,127
|
|
|
2,691
|
|
||
Product development
|
|
|
|
|
3,162
|
|
|
2,495
|
|
||
Sales and marketing
|
|
|
|
|
16,570
|
|
|
14,176
|
|
||
General and administrative
|
|
|
|
|
6,287
|
|
|
5,715
|
|
||
Depreciation
|
|
|
|
|
1,251
|
|
|
1,051
|
|
||
Amortization of intangible assets
|
|
|
|
|
1,840
|
|
|
2,539
|
|
||
Change in acquisition related contingencies
|
|
|
|
|
—
|
|
|
655
|
|
||
Total operating expenses
|
|
|
|
|
32,237
|
|
|
29,322
|
|
||
Operating income
|
|
|
|
|
13,895
|
|
|
10,767
|
|
||
Interest expense
|
|
|
|
|
(317
|
)
|
|
(444
|
)
|
||
Interest income
|
|
|
|
|
12
|
|
|
24
|
|
||
Income before income taxes
|
|
|
|
|
13,590
|
|
|
10,347
|
|
||
Income tax expense
|
|
|
|
|
4,971
|
|
|
3,760
|
|
||
Net income
|
|
|
|
|
$
|
8,619
|
|
|
$
|
6,587
|
|
|
|
|
|
|
|
|
|
||||
Basic earnings per share
|
|
|
|
|
$
|
0.13
|
|
|
$
|
0.10
|
|
Diluted earnings per share
|
|
|
|
|
$
|
0.13
|
|
|
$
|
0.09
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average basic shares outstanding
|
|
|
|
|
64,118
|
|
|
65,342
|
|
||
Weighted-average diluted shares outstanding
|
|
|
|
|
67,371
|
|
|
70,092
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
|
|
2012
|
|
2011
|
||||
Net income
|
|
|
|
|
$
|
8,619
|
|
|
$
|
6,587
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency translation adjustment
|
|
|
|
|
2,080
|
|
|
(2,919
|
)
|
||
Unrealized gains on investments, net of tax of $3 and $0
|
|
|
|
4
|
|
|
1
|
|
|||
Total other comprehensive income (loss)
|
|
|
|
|
2,084
|
|
|
(2,918
|
)
|
||
Comprehensive income
|
|
|
|
|
$
|
10,703
|
|
|
$
|
3,669
|
|
|
Three Months Ended March 31,
|
||||||
|
2012
|
|
2011
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
8,619
|
|
|
$
|
6,587
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|
|
|
||||
Depreciation
|
1,251
|
|
|
1,051
|
|
||
Amortization of intangible assets
|
1,840
|
|
|
2,539
|
|
||
Deferred income taxes
|
(710
|
)
|
|
(782
|
)
|
||
Amortization of deferred financing costs
|
115
|
|
|
117
|
|
||
Share based compensation
|
1,524
|
|
|
972
|
|
||
Change in acquisition related contingencies
|
—
|
|
|
655
|
|
||
Change in accrual for unrecognized tax benefits
|
209
|
|
|
106
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
2,063
|
|
|
(1,105
|
)
|
||
Prepaid expenses and other assets
|
(651
|
)
|
|
(921
|
)
|
||
Accounts payable and accrued expenses
|
(109
|
)
|
|
(3,186
|
)
|
||
Income taxes receivable/payable
|
612
|
|
|
(755
|
)
|
||
Deferred revenue
|
8,588
|
|
|
9,507
|
|
||
Other, net
|
16
|
|
|
8
|
|
||
Net cash flows from operating activities
|
23,367
|
|
|
14,793
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of fixed assets
|
(1,433
|
)
|
|
(730
|
)
|
||
Purchases of investments
|
(1,735
|
)
|
|
—
|
|
||
Maturities and sales of investments
|
749
|
|
|
850
|
|
||
Net cash flows from investing activities
|
(2,419
|
)
|
|
120
|
|
||
Cash flows from financing activities:
|
|
|
|
||||
Payments on long-term debt
|
(1,000
|
)
|
|
(20,000
|
)
|
||
Proceeds from sale of common stock
|
—
|
|
|
11,943
|
|
||
Purchase of treasury stock related to option exercises
|
—
|
|
|
(11,943
|
)
|
||
Payments under stock repurchase plan
|
(12,117
|
)
|
|
—
|
|
||
Payment of acquisition related contingencies
|
(1,557
|
)
|
|
(230
|
)
|
||
Proceeds from stock option exercises
|
634
|
|
|
2,809
|
|
||
Purchase of treasury stock related to vested restricted stock
|
(408
|
)
|
|
(171
|
)
|
||
Excess tax benefit over book expense from stock options exercised
|
257
|
|
|
4,522
|
|
||
Net cash flows from financing activities
|
(14,191
|
)
|
|
(13,070
|
)
|
||
Effect of exchange rate changes
|
772
|
|
|
1,285
|
|
||
Net change in cash and cash equivalents for the period
|
7,529
|
|
|
3,128
|
|
||
Cash and cash equivalents, beginning of period
|
55,237
|
|
|
43,030
|
|
||
Cash and cash equivalents, end of period
|
$
|
62,766
|
|
|
$
|
46,158
|
|
•
|
Level 1 – Quoted prices for identical instruments in active markets.
|
•
|
Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
|
•
|
Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
As of March 31, 2012
|
||||||||||||||
Fair Value Measurements Using
|
|
Total
|
|||||||||||||
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
|
|
Significant Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
||||||||||
Money market funds
|
$
|
26,720
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
26,720
|
|
Investments
|
—
|
|
|
5,966
|
|
|
—
|
|
|
5,966
|
|
|
As of December 31, 2011
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
|
|
Significant Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
|||||||||
Money market funds
|
$
|
25,383
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
25,383
|
|
Investments
|
—
|
|
|
4,983
|
|
|
—
|
|
|
4,983
|
|
||||
Contingent consideration to be paid in cash for the acquisitions
|
—
|
|
|
—
|
|
|
1,557
|
|
|
1,557
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
|
|
2012
|
|
2011
|
||||
Contingent consideration for acquisitions
|
|
|
|
|
|
|
|
||||
Balance at beginning of period
|
|
|
|
|
$
|
1,557
|
|
|
$
|
11,370
|
|
Cash payments
|
|
|
|
|
(1,557
|
)
|
|
(230
|
)
|
||
Change in estimates included in earnings
|
|
|
|
|
—
|
|
|
655
|
|
||
Balance at end of period
|
|
|
|
|
$
|
—
|
|
|
$
|
11,795
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2012
|
||||||||||||
|
Maturity
|
|
Gross
Amortized Cost
|
|
Gross Unrealized
Gain (Loss)
|
|
Estimated
Fair Value
|
||||||
U.S. Government and agencies
|
Within one year
|
|
$
|
754
|
|
|
$
|
1
|
|
|
$
|
755
|
|
U.S. Government and agencies
|
1 to 5 years
|
|
2,528
|
|
|
—
|
|
|
2,528
|
|
|||
Certificates of deposit
|
Within one year
|
|
490
|
|
|
1
|
|
|
491
|
|
|||
Certificates of deposit
|
1 to 5 years
|
|
2,184
|
|
|
8
|
|
|
2,192
|
|
|||
Total
|
|
|
$
|
5,956
|
|
|
$
|
10
|
|
|
$
|
5,966
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||
|
As of December 31, 2011
|
||||||||||||
|
Maturity
|
|
Gross
Amortized Cost
|
|
Gross Unrealized
Gain
|
|
Estimated
Fair Value
|
||||||
U.S. Government and agencies
|
Within one year
|
|
$
|
759
|
|
|
$
|
1
|
|
|
$
|
760
|
|
U.S. Government and agencies
|
1 to 5 years
|
|
1,516
|
|
|
2
|
|
|
1,518
|
|
|||
Certificates of deposit
|
Within one year
|
|
1,239
|
|
|
1
|
|
|
1,240
|
|
|||
Certificates of deposit
|
1 to 5 years
|
|
1,464
|
|
|
1
|
|
|
1,465
|
|
|||
Total
|
|
|
$
|
4,978
|
|
|
$
|
5
|
|
|
$
|
4,983
|
|
|
|
|
|
|
As of March 31, 2012
|
||||||||||||||||
|
|
|
|
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Acquired
Intangible
Assets, Net
|
|
Weighted-
Average
Amortization
Period
|
||||||||
Technology
|
|
|
|
|
$
|
17,500
|
|
|
$
|
(14,031
|
)
|
|
$
|
(61
|
)
|
|
$
|
3,408
|
|
|
3.8 years
|
Trademarks and brand names—Dice
|
|
39,000
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
|
Indefinite
|
|||||||
Trademarks and brand names—Other
|
|
15,490
|
|
|
(8,067
|
)
|
|
(498
|
)
|
|
6,925
|
|
|
5.1 years
|
|||||||
Customer lists
|
|
|
|
|
41,513
|
|
|
(37,699
|
)
|
|
(724
|
)
|
|
3,090
|
|
|
4.6 years
|
||||
Candidate database
|
|
|
|
|
28,241
|
|
|
(25,987
|
)
|
|
(46
|
)
|
|
2,208
|
|
|
3.0 years
|
||||
Acquired intangible assets, net
|
|
$
|
141,744
|
|
|
$
|
(85,784
|
)
|
|
$
|
(1,329
|
)
|
|
$
|
54,631
|
|
|
|
|
As of December 31, 2011
|
||||||||||||||||
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Acquired
Intangible
Assets, Net
|
|
Weighted-
Average
Amortization
Period
|
||||||||
Technology
|
$
|
18,000
|
|
|
$
|
(14,277
|
)
|
|
$
|
(61
|
)
|
|
$
|
3,662
|
|
|
3.8 years
|
Trademarks and brand names—Dice
|
39,000
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
|
Indefinite
|
||||
Trademarks and brand names—Other
|
16,790
|
|
|
(9,095
|
)
|
|
(495
|
)
|
|
7,200
|
|
|
5.1 years
|
||||
Customer lists
|
41,513
|
|
|
(37,430
|
)
|
|
(720
|
)
|
|
3,363
|
|
|
4.6 years
|
||||
Candidate database
|
28,241
|
|
|
(24,949
|
)
|
|
(46
|
)
|
|
3,246
|
|
|
3.0 years
|
||||
Acquired intangible assets, net
|
$
|
143,544
|
|
|
$
|
(85,751
|
)
|
|
$
|
(1,322
|
)
|
|
$
|
56,471
|
|
|
|
April 1, 2012 through December 31, 2012
|
$
|
3,634
|
|
2013
|
3,167
|
|
|
2014
|
2,850
|
|
|
2015
|
2,016
|
|
|
2016
|
934
|
|
|
2017 and thereafter
|
3,030
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
Amounts Borrowed:
|
|
|
|
||||
LIBOR rate loans
|
$
|
14,000
|
|
|
$
|
15,000
|
|
Total borrowed
|
$
|
14,000
|
|
|
$
|
15,000
|
|
|
|
|
|
||||
Term loan facility
|
$
|
14,000
|
|
|
$
|
15,000
|
|
Revolving credit facility
|
—
|
|
|
—
|
|
||
Total borrowed
|
$
|
14,000
|
|
|
$
|
15,000
|
|
|
|
|
|
||||
Maximum available to be borrowed under revolving facility
|
$
|
70,000
|
|
|
$
|
70,000
|
|
|
|
|
|
||||
Interest rates:
|
|
|
|
||||
LIBOR option:
|
|
|
|
||||
Interest margin
|
2.75
|
%
|
|
2.75
|
%
|
||
Actual interest rates
|
2.99
|
%
|
|
3.04
|
%
|
April 1, 2012 through December 31, 2012
|
$
|
1,139
|
|
2013
|
1,044
|
|
|
2014
|
969
|
|
|
2015
|
975
|
|
|
2016 and thereafter
|
3,973
|
|
|
Total minimum payments
|
$
|
8,100
|
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||||
|
|
|
|
|
|
|
|
||||
Foreign currency translation adjustment, net of tax of $1,336 and $1,336
|
|
|
|
$
|
(9,975
|
)
|
|
$
|
(12,055
|
)
|
|
Unrealized gains on investments, net of tax of $3 and $0
|
|
|
|
7
|
|
|
3
|
|
|||
Total accumulated other comprehensive loss, net
|
|
$
|
(9,968
|
)
|
|
$
|
(12,052
|
)
|
|
|
Three Months Ended March 31, 2012
|
|
Three Months Ended March 31, 2011
|
||||||||||
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
|
550,250
|
|
|
$
|
12.98
|
|
|
140,000
|
|
|
$
|
6.59
|
|
Granted- Restricted Stock
|
|
773,000
|
|
|
$
|
8.97
|
|
|
414,500
|
|
|
$
|
14.50
|
|
Forfeited during the period
|
|
(6,750
|
)
|
|
$
|
12.78
|
|
|
—
|
|
|
$
|
—
|
|
Vested during the period
|
|
(128,431
|
)
|
|
$
|
12.60
|
|
|
(29,000
|
)
|
|
$
|
6.08
|
|
Non-vested at end of period
|
|
1,188,069
|
|
|
$
|
10.41
|
|
|
525,500
|
|
|
$
|
12.86
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2012
|
|
2011
|
||||
The weighted average fair value of options granted
|
|
$
|
4.48
|
|
|
$
|
6.34
|
|
Dividend yield
|
|
—
|
%
|
|
—
|
%
|
||
Weighted average risk free interest rate
|
|
0.84
|
%
|
|
2.16
|
%
|
||
Weighted average expected volatility
|
|
61.39
|
%
|
|
49.92
|
%
|
||
Expected life (in years)
|
|
4.6
|
|
|
4.6
|
|
|
Three Months Ended March 31, 2012
|
||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
||||
Options outstanding at beginning of period
|
8,826,199
|
|
|
$
|
4.19
|
|
|
38,284,701
|
|
Granted
|
483,000
|
|
|
$
|
8.97
|
|
|
—
|
|
Exercised
|
(234,982
|
)
|
|
$
|
2.71
|
|
|
1,622,440
|
|
Forfeited
|
(17,000
|
)
|
|
$
|
5.14
|
|
|
—
|
|
Options outstanding at end of period
|
9,057,217
|
|
|
$
|
4.48
|
|
|
45,552,154
|
|
Exercisable at end of period
|
7,128,732
|
|
|
$
|
3.72
|
|
|
40,397,521
|
|
|
Three Months Ended March 31, 2011
|
||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
||||
Options outstanding at beginning of period
|
10,763,097
|
|
|
$
|
3.57
|
|
|
116,085,316
|
|
Granted
|
291,000
|
|
|
$
|
14.50
|
|
|
—
|
|
Exercised
|
(1,193,099
|
)
|
|
$
|
2.35
|
|
|
14,143,145
|
|
Forfeited
|
(43,938
|
)
|
|
$
|
5.50
|
|
|
—
|
|
Options outstanding at end of period
|
9,817,060
|
|
|
$
|
4.03
|
|
|
108,801,867
|
|
Exercisable at end of period
|
6,944,232
|
|
|
$
|
3.05
|
|
|
83,729,685
|
|
|
|
Options Outstanding
|
|
Options
Exercisable
|
|||||
Exercise Price
|
|
Number
Outstanding
|
|
Weighted-
Average
Remaining
Contractual
Life
|
|
Number
Exercisable
|
|||
|
|
|
|
(in years)
|
|
|
|||
$ 0.20 - $ 0.99
|
|
1,452,527
|
|
|
3.4
|
|
|
1,452,527
|
|
$ 1.00 - $ 3.99
|
|
2,813,129
|
|
|
3.6
|
|
|
2,422,279
|
|
$ 4.00 - $ 5.99
|
|
606,260
|
|
|
4.6
|
|
|
584,603
|
|
$ 6.00 - $ 8.99
|
|
3,735,263
|
|
|
4.5
|
|
|
2,525,674
|
|
$ 9.00 - $ 14.50
|
|
450,038
|
|
|
5.8
|
|
|
143,649
|
|
|
|
9,057,217
|
|
|
|
|
7,128,732
|
|
|
Three Months Ended March 31,
|
||||||
|
2012
|
|
2011
|
||||
By Segment:
|
|
|
|
||||
Revenues:
|
|
|
|
||||
Tech & Clearance
|
$
|
31,060
|
|
|
$
|
25,689
|
|
Finance
|
10,000
|
|
|
10,576
|
|
||
Energy
|
4,045
|
|
|
3,075
|
|
||
Other
|
1,027
|
|
|
749
|
|
||
Total revenues
|
$
|
46,132
|
|
|
$
|
40,089
|
|
|
|
|
|
||||
Depreciation:
|
|
|
|
||||
Tech & Clearance
|
$
|
1,015
|
|
|
$
|
852
|
|
Finance
|
149
|
|
|
125
|
|
||
Energy
|
23
|
|
|
30
|
|
||
Other
|
64
|
|
|
44
|
|
||
Total depreciation
|
$
|
1,251
|
|
|
$
|
1,051
|
|
|
|
|
|
||||
Amortization:
|
|
|
|
||||
Finance
|
$
|
—
|
|
|
$
|
242
|
|
Energy
|
1,734
|
|
|
1,998
|
|
||
Other
|
106
|
|
|
299
|
|
||
Total amortization
|
$
|
1,840
|
|
|
$
|
2,539
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||||
|
|
|
|
|
2012
|
|
2011
|
||||
|
|
|
|
|
|
|
|
||||
Operating income (loss):
|
|
|
|
|
|
|
|
||||
Tech & Clearance
|
|
|
|
|
$
|
11,710
|
|
|
$
|
8,893
|
|
Finance
|
|
|
|
|
3,260
|
|
|
4,148
|
|
||
Energy
|
|
|
|
|
(461
|
)
|
|
(1,487
|
)
|
||
Other
|
|
|
|
|
(614
|
)
|
|
(787
|
)
|
||
Operating income
|
|
|
|
|
13,895
|
|
|
10,767
|
|
||
Interest expense
|
|
|
|
|
(317
|
)
|
|
(444
|
)
|
||
Interest income
|
|
|
|
|
12
|
|
|
24
|
|
||
Income before income taxes
|
|
|
|
|
$
|
13,590
|
|
|
$
|
10,347
|
|
|
|
|
|
|
|
|
|
||||
Capital expenditures:
|
|
|
|
|
|
|
|
||||
Tech & Clearance
|
|
|
|
|
$
|
1,154
|
|
|
$
|
807
|
|
Finance
|
|
|
|
|
95
|
|
|
124
|
|
||
Energy
|
|
|
|
|
5
|
|
|
21
|
|
||
Other
|
|
|
|
|
98
|
|
|
29
|
|
||
Total capital expenditures
|
|
|
|
|
$
|
1,352
|
|
|
$
|
981
|
|
|
|
|
|
|
|
|
|
||||
By Geography:
|
|
|
|
|
|
|
|
||||
Revenues:
|
|
|
|
|
|
|
|
||||
U.S.
|
|
|
|
|
$
|
36,397
|
|
|
$
|
30,561
|
|
Non- U.S.
|
|
|
|
|
9,735
|
|
|
9,528
|
|
||
Total revenues
|
|
|
|
|
$
|
46,132
|
|
|
$
|
40,089
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
Total assets:
|
|
|
|
||||
Tech & Clearance
|
$
|
165,146
|
|
|
$
|
160,903
|
|
Finance
|
108,011
|
|
|
104,490
|
|
||
Energy
|
56,092
|
|
|
56,346
|
|
||
Other
|
4,259
|
|
|
4,639
|
|
||
Total assets
|
$
|
333,508
|
|
|
$
|
326,378
|
|
|
Tech & Clearance
|
|
Finance
|
|
Energy
|
|
Other
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance, December 31, 2011
|
$
|
84,778
|
|
|
$
|
53,172
|
|
|
$
|
35,104
|
|
|
$
|
3,311
|
|
|
$
|
176,365
|
|
Foreign currency translation adjustment
|
—
|
|
|
1,551
|
|
|
—
|
|
|
—
|
|
|
1,551
|
|
|||||
Goodwill at March 31, 2012
|
$
|
84,778
|
|
|
$
|
54,723
|
|
|
$
|
35,104
|
|
|
$
|
3,311
|
|
|
$
|
177,916
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||||
|
|
|
|
|
2012
|
|
2011
|
||||
Income from continuing operations—basic and diluted
|
|
|
|
|
$
|
8,619
|
|
|
$
|
6,587
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average shares outstanding—basic
|
|
|
|
|
64,118
|
|
|
65,342
|
|
||
Add shares issuable upon exercise of stock options
|
|
|
|
|
3,253
|
|
|
4,750
|
|
||
Weighted-average shares outstanding—diluted
|
|
|
|
|
67,371
|
|
|
70,092
|
|
||
|
|
|
|
|
|
|
|
||||
Basic earnings per share
|
|
|
|
|
$
|
0.13
|
|
|
$
|
0.10
|
|
Diluted earnings per share
|
|
|
|
|
$
|
0.13
|
|
|
$
|
0.09
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Three Months Ended March 31,
|
|
Increase (Decrease)
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Tech & Clearance
|
$
|
31,060
|
|
|
$
|
25,689
|
|
|
$
|
5,371
|
|
|
20.9
|
%
|
Finance
|
10,000
|
|
|
10,576
|
|
|
(576
|
)
|
|
(5.4
|
)%
|
|||
Energy
|
4,045
|
|
|
3,075
|
|
|
970
|
|
|
31.5
|
%
|
|||
Other
|
1,027
|
|
|
749
|
|
|
278
|
|
|
37.1
|
%
|
|||
Total revenues
|
$
|
46,132
|
|
|
$
|
40,089
|
|
|
$
|
6,043
|
|
|
15.1
|
%
|
|
Three Months Ended March 31,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Cost of revenues
|
$
|
3,127
|
|
|
$
|
2,691
|
|
|
$
|
436
|
|
|
16.2
|
%
|
Percentage of revenues
|
6.8
|
%
|
|
6.7
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Product Development
|
$
|
3,162
|
|
|
$
|
2,495
|
|
|
$
|
667
|
|
|
26.7
|
%
|
Percentage of revenues
|
6.9
|
%
|
|
6.2
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Sales and Marketing
|
$
|
16,570
|
|
|
$
|
14,176
|
|
|
$
|
2,394
|
|
|
16.9
|
%
|
Percentage of revenues
|
35.9
|
%
|
|
35.4
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
General and administrative
|
$
|
6,287
|
|
|
$
|
5,715
|
|
|
$
|
572
|
|
|
10.0
|
%
|
Percentage of revenues
|
13.6
|
%
|
|
14.3
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Depreciation
|
$
|
1,251
|
|
|
$
|
1,051
|
|
|
$
|
200
|
|
|
19.0
|
%
|
Percentage of revenues
|
2.7
|
%
|
|
2.6
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Amortization
|
$
|
1,840
|
|
|
$
|
2,539
|
|
|
$
|
(699
|
)
|
|
(27.5
|
)%
|
Percentage of revenues
|
4.0
|
%
|
|
6.3
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2012
|
|
2011
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Interest expense
|
$
|
317
|
|
|
$
|
444
|
|
|
$
|
(127
|
)
|
|
(28.6
|
)%
|
Percentage of revenues
|
0.7
|
%
|
|
1.1
|
%
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
2012
|
|
2011
|
|||||
(in thousands, except
percentages)
|
|||||||
Income before income taxes
|
$
|
13,590
|
|
|
$
|
10,347
|
|
Income tax expense
|
4,971
|
|
|
3,760
|
|
||
Effective tax rate
|
36.6
|
%
|
|
36.3
|
%
|
•
|
Adjusted EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;
|
•
|
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
|
•
|
Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on your debt;
|
•
|
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements; and
|
•
|
Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
|
|
For the three months ended March 31,
|
||||||
2012
|
|
2011
|
|||||
Reconciliation of Net Income to Adjusted EBITDA:
|
|
|
|
||||
Net income
|
$
|
8,619
|
|
|
$
|
6,587
|
|
Interest expense
|
317
|
|
|
444
|
|
||
Interest income
|
(12
|
)
|
|
(24
|
)
|
||
Income tax expense
|
4,971
|
|
|
3,760
|
|
||
Depreciation
|
1,251
|
|
|
1,051
|
|
||
Amortization of intangible assets
|
1,840
|
|
|
2,539
|
|
||
Change in acquisition related contingencies
|
—
|
|
|
655
|
|
||
Non-cash stock compensation expense
|
1,524
|
|
|
972
|
|
||
Other income
|
—
|
|
|
(44
|
)
|
||
Adjusted EBITDA
|
$
|
18,510
|
|
|
$
|
15,940
|
|
|
|
|
|
||||
Reconciliation of Operating Cash Flows to Adjusted EBITDA:
|
|
|
|
||||
Net cash provided by operating activities
|
$
|
23,367
|
|
|
$
|
14,793
|
|
Interest expense
|
317
|
|
|
444
|
|
||
Amortization of deferred financing costs
|
(115
|
)
|
|
(117
|
)
|
||
Interest income
|
(12
|
)
|
|
(24
|
)
|
||
Income tax expense
|
4,971
|
|
|
3,760
|
|
||
Deferred income taxes
|
710
|
|
|
782
|
|
||
Change in accrual for unrecognized tax benefits
|
(209
|
)
|
|
(106
|
)
|
||
Change in accounts receivable
|
(2,063
|
)
|
|
1,105
|
|
||
Change in deferred revenue
|
(8,588
|
)
|
|
(9,507
|
)
|
||
Changes in working capital and other
|
132
|
|
|
4,810
|
|
||
Adjusted EBITDA
|
$
|
18,510
|
|
|
$
|
15,940
|
|
|
Three Months Ended March 31,
|
||||||
2012
|
|
2011
|
|||||
Net cash provided by operating activities
|
$
|
23,367
|
|
|
$
|
14,793
|
|
Purchases of fixed assets
|
(1,433
|
)
|
|
(730
|
)
|
||
Free cash flow
|
$
|
21,934
|
|
|
$
|
14,063
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2012
|
|
2011
|
|||||
Cash from operating activities
|
|
|
|
$
|
23,367
|
|
|
$
|
14,793
|
|
Cash from investing activities
|
|
|
|
(2,419
|
)
|
|
120
|
|
||
Cash from financing activities
|
|
|
|
(14,191
|
)
|
|
(13,070
|
)
|
|
Payments by period
|
|||||||||||||||||||
Total
|
|
April 1, 2012 through December 31, 2012
|
|
2013-2014
|
|
2015
|
|
Thereafter
|
||||||||||||
|
(in thousands)
|
|||||||||||||||||||
Credit Agreement
|
$
|
14,000
|
|
|
$
|
3,000
|
|
|
$
|
11,000
|
|
|
$
|
—
|
|
—
|
|
$
|
—
|
|
Operating lease obligations
|
8,100
|
|
|
1,139
|
|
|
2,013
|
|
|
975
|
|
|
3,973
|
|
||||||
Total contractual obligations
|
$
|
22,100
|
|
|
$
|
4,139
|
|
|
$
|
13,013
|
|
|
$
|
975
|
|
|
$
|
3,973
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period
|
|
(a) Total Number of Shares Purchased [1]
|
|
(b) Average Price Paid per Share
|
|
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
(d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs [2]
|
|||||||||||||
January 1 through January 31, 2012
|
|
200,000
|
|
|
|
$
|
8.79
|
|
|
|
200,000
|
|
|
|
$
|
8,320,958
|
|
|
|||
February 1 through February 29, 2012
|
|
682,024
|
|
|
|
8.90
|
|
|
|
682,024
|
|
|
|
2,249,878
|
|
|
|||||
March 1 through March 31, 2012
|
|
473,435
|
|
|
|
9.34
|
|
|
|
473,435
|
|
|
|
62,826,011
|
|
|
|||||
Total
|
|
1,355,459
|
|
|
|
$
|
9.04
|
|
|
|
1,355,459
|
|
|
|
|
|
Item 3.
|
Defaults Upon Senior Securities
|
Item 4.
|
Mine Safety Disclosures
|
Item 5.
|
Other Information
|
Nominee
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
H. Raymond Bingham
|
|
49,711,833
|
|
6,172,155
|
|
3,436,374
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
58,280,212
|
|
124,221
|
|
915,929
|
|
—
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
53,471,960
|
|
1,587,572
|
|
824,456
|
|
3,436,374
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
42,777,261
|
|
12,280,024
|
|
826,703
|
|
3,436,374
|
Item 6.
|
Exhibits
|
10.1*
|
|
Employment Agreement dated as of February 27, 2012 between Dice Inc. and Bennett Smith.
|
10.2*
|
|
Employment Agreement dated as of November 16, 2004, and amended as of July 1, 2011 between eFinancialCareers Limited and James Bennett.
|
10.3*
|
|
Second Amendment to Credit Agreement dated February 17, 2012, among Dice Holdings, Inc., Dice Inc. and Dice Career Solutions, Inc., as Borrowers, the various lenders party thereto, Bank of America, N.A., as administrative agent, and Banc of America Securities LLC, J.P. Morgan Securities, Inc. and Key Bank Capital Markets Inc., as Joint Lead Arrangers and Co-Book Managers.
|
31.1*
|
|
Certification of Scot W. Melland, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2*
|
|
Certification of Michael P. Durney, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1*
|
|
Certification of Scot W. Melland, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2*
|
|
Certification of Michael P. Durney, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101.INS**
|
|
XBRL Instance Document.
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB**
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
Filed herewith.
|
**
|
XBRL information is deemed not filed or a part of a registration statement or prospectus for purposes of Sections 11 and 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under such sections.
|
|
|
|
D
ICE
H
OLDINGS
, I
NC
.
|
|
Date:
|
April 25, 2012
|
Registrant
|
||
|
|
|
|
|
|
|
|
|
/
S
/ SCOT W. MELLAND
|
|
|
|
|
Scot W. Melland
|
|
|
|
|
Chairman, President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
/
S
/ MICHAEL P. DURNEY
|
|
|
|
|
Michael P. Durney, CPA
|
|
|
|
|
Senior Vice President, Finance and Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
10.1*
|
|
Employment Agreement dated as of February 27, 2012 between Dice Inc. and Bennett Smith.
|
10.2*
|
|
Employment Agreement dated as of November 16, 2004, and amended as of July 1, 2011 between eFinancialCareers Limited and James Bennett.
|
10.3*
|
|
Second Amendment to Credit Agreement dated February 17, 2012, among Dice Holdings, Inc., Dice Inc. and Dice Career Solutions, Inc., as Borrowers, the various lenders party thereto, Bank of America, N.A., as administrative agent, and Banc of America Securities LLC, J.P. Morgan Securities, Inc. and Key Bank Capital Markets Inc., as Joint Lead Arrangers and Co-Book Managers.
|
31.1*
|
|
Certification of Scot W. Melland, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2*
|
|
Certification of Michael P. Durney, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1*
|
|
Certification of Scot W. Melland, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2*
|
|
Certification of Michael P. Durney, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101.INS**
|
|
XBRL Instance Document.
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB**
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
|
Filed herewith
|
**
|
|
XBRL information is deemed not filed or a part of a registration statement or prospectus for purposes of Sections 11 and 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under such sections.
|
3.1
|
You will be required to work during normal business hours from Monday to Friday and such other hours as may be reasonably necessary for the proper performance of your duties for the Company.
|
3.2
|
You are to devote the whole of your working time to the business of the Company, unless prevented by ill health or injury. You may not (without the prior written consent of the Chief Executive of the Company) accept any other appointment. Without such consent you may also not be directly or indirectly engaged in, concerned with or financially interested in any other business, except through a holding for investment purposes only of not more than three per cent in any class of shares or securities in any company listed or dealt in on any recognised stock exchange. You may not undertake any paid work in your spare time without the prior written approval of the Chief Executive of the Company, who will need to be satisfied that this will not affect the performance of your duties.
|
3.3.1
|
You will perform such duties for the Company and exercise such powers as the Board or the Chief Executive of the Company, and the Chief Executive of the Careers division, may require. Those duties are to be carried out loyally, diligently and in accordance with the directions of the Board or the Chief Executives. You should keep them properly informed about the business of the Company and promote and protect the interests of the Company, not knowingly or deliberately doing anything, which is to its detriment.
|
3.4
|
You agree to the Company holding and processing, both electronically and manually, the data which it collects relating to you in connection with your employment for the purpose of its business, administering and managing its employees, and complying with applicable laws, regulations and procedures.
|
4.
|
Salary and Expenses
|
4.1
|
You will be paid a salary at the rate of
£95,000
per annum. Your salary will accrue from day to day and will be paid by equal installments in arrears and normally on the last day of each month, subject to such deductions as are required by law or under the terms of your employment.
|
4.2
|
You will also be paid a minimum bonus of £17,500 in respect of the year ending 31 December 2005, payable in four equal installments in April 2005, July 2005, October 2005 and January 2006 provided you are employed by the Company on the last day of each of those months.
|
4.3
|
For the year ending 31 December 2006, minimum combined salary and bonus will be £112,500 provided you are employed by the Company up to 31 December 2006.
|
4.4
|
You will be entitled, on production of satisfactory evidence of expenditure, to be reimbursed for reasonable out-of-pocket expenses wholly and properly incurred by you in the performance of your duties. Any credit card supplied to you by the Company may only be used for expenses incurred by you in the performance of those duties.
|
4.5
|
The Group may withhold the payment of any money owing or due to be paid to you if you are in breach of the terms of this Agreement and may withhold or deduct any money owing or due to be paid by you to it under this Agreement or otherwise from any money owing or due to be paid to you.
|
5.
|
Ill Health and Injury
|
5.1
|
If you are unable to perform your duties as a result of ill health or injury, you will be entitled, for so long as your employment continues, to your salary during any period of incapacity of not more than 30 days (whether consecutive or not) in any period of 52 consecutive weeks. The payment of such salary will be subject to the production of satisfactory evidence from a registered medical practitioner in respect of any period of absence of more than seven consecutive days and will include any statutory sick pay and other social security benefits to which you are or may be entitled. Your qualifying days for statutory sick pay are Monday to Friday.
|
5.2
|
You will promptly inform the Company if you are unable to perform your duties as a result of ill health or injury caused by a third party and for which compensation may be recoverable. In return for the Company continuing to pay your salary and to provide other benefits during your employment, you will take such action as the Company may reasonably request to pursue a claim against such third party, in order to recover for the benefit of the Company the costs of continuing your employment. You will keep the Company regularly informed of the progress of any claim, provide such information about it as the Company may from time to time reasonably require, and will immediately notify the Company in writing of the compromise, settlement, award or judgment. You will, if you are asked to do so, refund to the Company the lesser of the amount recovered by you (after deducting any related costs borne by you) and the aggregate cost of the salary and other benefits paid to you during your ill health or injury and will hold these proceeds on trust for the Company to apply them in repayment of this obligation.
|
5.3.1
|
You will from time to time upon request submit yourself to a medical examination at the Company's expense by a suitably qualified person of the Company's choice, if you are unable to perform your duties for the Group as a result of ill health or injury. If that person is unable to confirm that you are fit to perform your duties or if there are factors which such person considers are relevant to the performance of those duties, you will co-operate in ensuring the prompt delivery of all relevant medical reports to the Company and will allow the Company access to any relevant medical report which has been prepared by a medical practitioner responsible for your clinical care.
|
6.
|
Holidays
|
7.
|
Confidentiality and Company Property
|
7.1
|
During your employment you will have access to and will be entrusted with confidential information and trade secrets relating to the business of the Company. This includes but is not limited to information and secrets relating to:
|
7.2
|
You may not during your employment (otherwise than in the proper performance of your duties and then only to those who need to know such information or secrets) or afterwards (otherwise than with the prior written consent of the Board or as required by law) use or disclose any confidential information or trade secrets concerning the business of the Company or in respect of which the Company may be bound by an obligation of confidence to any third party. You should also use your best endeavors to prevent the publication or disclosure of such information or secrets. These restrictions will not apply after your employment has terminated to information which has become available to the public generally, otherwise than through unauthorised disclosure.
|
7.3
|
All notes, memoranda and other records (including those stored on computer software) made by you during your employment and relating to the business of the Company belong to the Company and should promptly be handed over to the Company (or as it may direct) from time to time.
|
8.
|
Intellectual-Property-Rights
|
8.1
|
Any trade mark, design or other copyright work created by you during your employment with the Company (and whether or not in conjunction with a third party) in connection with, affecting or relating to the business of the Company or capable of being used or adapted for use in it must immediately be disclosed to the Company and will belong to the relevant company in the Company. You will not infringe any rights in such works and will notify the Company immediately of any circumstances where such rights may have been infringed.
|
8.2
|
You agree that you will at the Company's expense and upon request (whether during after the termination of your employment) execute such documents as may be necessary to implement the provisions of this paragraph 8 and vest all rights, title and interest in such property in the relevant company in the Company.
|
9.
|
Disciplinary and Grievance Procedure
|
9.1
|
You are expected to exhibit a high standard of propriety, integrity and efficiency in all your dealings with and in the name of the Company. You may be suspended with pay or required to take any accrued holiday entitlement during any investigation which it may be necessary for the Company to undertake. There is a disciplinary procedure. If you are dissatisfied with any disciplinary decision, you may refer it to the Board, whose decision will be final.
|
9.2
|
If you have any grievance relating to your employment, you should refer it to the Chief Executive of the Company. If you are dissatisfied with this decision, you may refer the matter to the Board, whose decision will be final.
|
10.
|
Termination
|
10.1
|
The Company may, notwithstanding any other terms of your employment and irrespective of whether the grounds for termination arose before or after it began, at any time by notice in writing, terminate your employment with immediate effect:
|
(a)
|
if you have been unable to perform your duties by reason or ill health Injury for 30 days (whether consecutive or not) in any period of 52 consecutive weeks;
|
(b)
|
if you become of unsound mind, a patient for the purpose of any statute relating to mental health, a petition is presented or any order is made or any notice is issued convening a meeting for the purpose of passing a resolution for your bankruptcy or you become bankrupt or make any composition or enter into any deed of arrangement with your creditors generally;
|
(c)
|
if you are convicted of a criminal offence other than one which in the opinion of the Board does not affect your position as an employee of the Company, bearing in mind the nature of your duties and the capacity In which you are employed; or
|
(d)
|
if you are guilty of any serious default or misconduct in connection with or affecting the business of the Company, commit any serious or repeated breach of your obligations under your employment, are guilty of serious neglect or negligence in the performance of your duties or behave in a manner (whether on or off duty) which is likely to bring the Company into disrepute or which seriously impairs your ability to perform your duties.
|
10.2
|
Your employment will automatically cease without any notice being given on your 60th birthday.
|
10.3
|
If the Company wishes to terminate your employment or if you wish to leave its employment before the expiry of the notice in paragraph 2 and whether or not either party has given notice to the other under that
|
10.4
|
On the termination of your employment you will hand over to the Company all property (including company credit cards and keys) belonging to the Company or relating to its business, which may be in your possession or under your control and without you or anyone on your behalf keeping copies of any reproducible items and without having downloaded any information stored on any computer disk.
|
10.5
|
After the termination of your employment you will not at any time make any untrue or misleading statement about the Company or its officers or employees or represent yourself as being after such termination employed by or connected with the Company.
|
11.1
|
During your employment and for the periods set out below after its termination less any period during which you are not required to attend for work pursuant to paragraph 10.3, you will not (except with prior written consent of the Board) directly or indirectly do or attempt to do any of the following:
|
(a)
|
for 6 months undertake, carry on or be employed, engaged or interested in any capacity in either any business which is competitive with or similar to a Relevant Business within the Territory, or any business an objective or anticipated result of which is to compete with a Relevant Business within the Territory;
|
(b)
|
for 6 months entice, induce or encourage a Customer to transfer or remove custom from the Company or any Associated Company;
|
(c)
|
for 6 months solicit or accept business from a Customer for the supply of Competitive Services;
|
(d)
|
for 6 months entice, induce or encourage an Employee to leave or seek to leave his or her position with the Company or any Associated Company for the purpose of being involved in or concerned with either the supply of Competitive Services or a business which competes with or is similar to a Relevant Business or which plans to compete with a Relevant Business, regardless of whether or not that Employee acts in breach of his or her contract of employment with the Company or any Associated Company by so doing and regardless of whether the Relevant Business is within or outside the Territory.
|
11.2
|
For the purpose of this paragraph 11:
|
(a)
|
"Customer" means a person:
|
(i)
|
who at any time during the Relevant Period was a customer or client of the Company or any Associated Company (whether or not goods or services were actually provided during such period) or to whom at the expiry of the Relevant Period the Company or any Associated Company was actively and directly seeking to supply goods or services, in either case for the purpose of a Relevant Business; and
|
(b)
|
"Competitive Services" means goods or services identical or similar to or competitive with those which at the expiry of the Relevant Period the Company or any Associated Company was supplying or negotiating or actively and directly seeking to supply to a Customer for the purpose of a Relevant Business;
|
(c)
|
"Relevant Business" means the business of the Company or any Associated Company in which, pursuant to your duties, you were materially involved at any time during the Relevant Period.
|
(d)
|
"Territory" means England, Wales, Scotland and any other country or state in which the Company or any Associated Company is operating or planning to operate at the expiry of the Relevant Period. A business of the Company or any Associated Company will be operating within the Territory at the expiry of the Relevant Period if Relevant Services have been supplied during the Relevant Period. A business will be within the Territory if either any such business in which you are to be involved is located or to be located within the Territory or it is conducted or to be conducted wholly or partly within the Territory;
|
(e)
|
"Employee" means a person who is employed by or who renders services to the Company or any Associated Company in a Relevant Business in an advertising or managerial or marketing or sales or distribution or senior capacity and/or who has responsibility for or influence over customers or advertisers or who is in possession of confidential information about such customers or advertisers and who in either case was employed or so rendered services during the period of 12 months ending on the last day on which you actively worked under this Agreement for the Company or any Associated Company and who had dealings with you during that period.
|
11.3
|
Each sub-paragraph and part of such sub-paragraph of this paragraph 11 constitutes an entirely separate and independent restriction and does not operate to limit any other obligation owed by you, whether that obligation is express or implied by law. If any restriction is held to be invalid or unenforceable by a court of competent jurisdiction, it is intended and understood by the parties that such invalidity or unenforceability will not affect the remaining restrictions.
|
11.4
|
You acknowledge that before entering into this Agreement you had the opportunity to obtain legal advice and that each of the restrictions in this paragraph 11 goes no further than is necessary for the protection of the Company's and each Associated Company's legitimate business interests.
|
11.5
|
Before accepting any offer of employment either during your employment or during the continuance of the restrictions in this paragraph 11, you will immediately provide to the person making such offer a complete signed copy of this Agreement.
|
12.
|
Continuing Obligations
|
13.
|
Notices
|
14.
|
Interpretation
|
14.1
|
Definitions
|
(i)
|
a holding company (as defined by Section 736 of the Companies Act 1985) of the Company;
|
(ii)
|
a subsidiary (as defined by Section 736 of the Companies Act 1985) of the Company or of any holding company of the Company;
|
(iii)
|
a company over which the Company has control within the meaning of Section 840 of the income and Corporation Taxes Act 1988; or
|
(iv)
|
a subsidiary undertaking as defined by Section 258 of the Companies Act 1985;
|
"Board"
|
the Board of Directors of the Company including any duly appointed committee or nominee of the Board;
|
"Company"
|
eFinancialNews Limited
|
"day's salary"
|
1/260th of your salary;
|
"Effective Date"
|
start/contract date
, or the date upon which your notice period under your current contract of employment expires, if later;
|
“salary”
|
the salary payable from time to time under paragraph 4.1;
|
"termination"
|
the ending of your employment however it arises and irrespective of its cause or manner. Other than (in relation to paragraph 11) its wrongful termination by the Company.
|
14.2
|
Construction
|
(a)
|
The provisions of Schedule 13, Part 1 of the Companies Act 1985 will apply in determining whether you have an interest in any shares or other securities.
|
(b)
|
References to acting directly or indirectly will include acting alone or jointly with or on behalf of or by means of another person and/or giving advice or providing services with a view to assisting another person.
|
(c)
|
References to a person will include an individual, firm, corporation and any other organisation however it is constituted and words denoting the singular shall include the plural and vice versa.
|
(d)
|
The paragraph headings have been added for convenience only and will not affect the construction of this Agreement.
|
15.2
|
The terms of this Agreement constitute the entire agreement between us and no variation or addition to it and no waiver of any provision will be effective unless in writing and signed by both parties.
|
15.3
|
You will be accepting the terms of this letter on the basis that the Company is agreeing to its terms for itself and for each other Associated Company, with the intention that each such Company will be entitled to enforce the terms of this letter against you.
|
15.4
|
The terms of this letter will be construed in accordance with English law and both parties irrevocably submit to the non-exclusive jurisdiction of the English Courts to settle any disputes which may arise in connection with your employment.
|
April 25, 2012
|
|
/s/ Scot W. Melland
|
|
|
|
|
Scot W. Melland
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
Dice Holdings, Inc.
|
|
|
April 25, 2012
|
|
/s/ Michael P. Durney
|
|
|
|
|
Michael P. Durney
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
Dice Holdings, Inc.
|
|
|